Literature DB >> 4611919

Protection against gram-negative infections with antiserum to lipid A from Salmonella minnesota R595.

N A Mullan, P M Newsome, P G Cunnington, G H Palmer, M E Wilson.   

Abstract

The ability of antisera to lipid A, induced in rabbits by immunization with lipid A complexed to various carriers, to protect mice against gram-negative infection and to inhibit the fluid loss caused by an enteropathogenic strain of Escherichia coli in the piglet ligated gut was investigated. No significant protection was obtained in either case, although passive hemolysis and quantitative precipitation tests showed the presence of antilipid A antibodies in the sera. Fluorescent antibody studies suggest that the lipid A is in a cryptic position on the surface of smooth strains of gram-negative bacteria.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4611919      PMCID: PMC423086          DOI: 10.1128/iai.10.6.1195-1201.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Stimulation of natural immunity to Escherichia coli infection: observations on mice.

Authors:  D ROWLEY
Journal:  Lancet       Date:  1955-01-29       Impact factor: 79.321

2.  Biochemical studies on lipopolysaccharides of Salmonella R mutants. 6. Investigations on the structure of the lipid A component.

Authors:  J Gmeiner; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-01

3.  Interaction of lipopolysaccharides and lipid A with complement.

Authors:  C Galanos; E T Rietschel; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1971-03-01

4.  The importance of underlying disease in patients with gram-negative bacteremia.

Authors:  M A Freid; K L Vosti
Journal:  Arch Intern Med       Date:  1968-05

5.  Type-specific and cross-reactive antibodies in gram-negative bacteremia.

Authors:  W R McCabe; B E Kreger; M Johns
Journal:  N Engl J Med       Date:  1972-08-10       Impact factor: 91.245

6.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

7.  Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.

Authors:  W R McCabe
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

8.  Opsonizing and bactericidal activity of antibodies against common antigen of Enterobacteriaceae.

Authors:  G J Domingue; E Neter
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

9.  Common enterobacterial antigen. II. Effect of immunization on challenge with heterologous bacilli.

Authors:  W R McCabe; A Greely
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

10.  Increased resistance to infection and accompanying alteration in properidin levels following administration of bacterial lipopolysaccharides.

Authors:  M LANDY; L PILLEMER
Journal:  J Exp Med       Date:  1956-09-01       Impact factor: 14.307

View more
  24 in total

Review 1.  Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis.

Authors:  D L Dunn
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

2.  Inhibition of lipopolysaccharide mitogenicity with characterized anti-lipid A monoclonal antibodies.

Authors:  R Girard; R Chaby
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

3.  Effect of lipopolysaccharide and lipid A on mouse liver pyruvate kinase activity.

Authors:  S M Smith; I S Snyder
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

4.  Common lipopolysaccharide specificity: new type of antigen residing in the inner core region of S- and R-form lipopolysaccharides from different families of gram-negative bacteria.

Authors:  H Brade; C Galanos
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

Review 5.  Enterobacterial common antigen.

Authors:  P H Mäkelä; H Mayer
Journal:  Bacteriol Rev       Date:  1976-09

6.  Experimental Escherichia coli ascending pyelonephritis in rats: active peroral immunization with live Escherichia coli.

Authors:  I Mattsby-Baltzer; L A Hanson; S Olling; B Kaijser
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

7.  Lipid A and anti-lipid A.

Authors:  I Mattsby-Baltzer; B Kaijser
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

8.  Characteristics of lipid A-protein complex from endotoxin of Shigella dysenteriae type 1 (S and R strains).

Authors:  J Sourek; T Trnka; J Levin; J Roubal; C Michalec
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

9.  Effect of active and passive immunizations with lipid A and salmonella minnesota Re 595 on gram-negative infections in mice.

Authors:  L A Hodgin; J Drews
Journal:  Infection       Date:  1976       Impact factor: 3.553

10.  Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity.

Authors:  W C Bogard; D L Dunn; K Abernethy; C Kilgarriff; P C Kung
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.